Dr Alexander Jorge and Dr Alicia Romano invite you to view their presentations focusing on early genetic diagnosis and phenotype genotype relationships in Noonan syndrome and successful growth hormone therapy in Noonan syndrome.
Subtitled versions are available in German, Spanish, French, Italian, Portuguese, Japanese, and Chinese (simplified). Select your language when you launch the video presentation and have completed the pre-assessment questions.
Educational Grant: This program is made possible thanks to an independent educational grant from Novo Nordisk A/S.
Contact Us
eMail: IME@springer.com
Address: Springer Healthcare IME
The Campus, 4 Crinan Street
London, N1 9XW, UK
Associate Professor of Medicine at The University of São Paulo (USP), School of Medicine, Brazil
Alexander Jorge is a clinical endocrinologist as well as a translational researcher. He is a principal investigator at the Developmental Endocrinology Unit and Genetic Endocrinology Unit. Dr Jorge is an expert in growth disorders and has published more than 100 papers in various international scientific journals. He is responsible for molecular genetic investigation of several endocrine genetic disorders at the largest hospital in South America (Hospital das Clínicas de São Paulo). His research is centered on discovering and understanding the genetic mechanisms involved in monogenic endocrine diseases, in particular those associated with growth and development disorders.
Dr Alexander Jorge has received speaker fees from Merck KGAa Darmstadt Germany and Novo Nordisk in the past 12 months.
Associate Professor of Pediatrics, New York Medical College, Valhalla, NY, USA
Alicia A. Romano, MD, is a graduate of The State University of New York at Stony Brook School of Medicine. She completed her Pediatric Internship, Residency, and Pediatric Endocrine Fellowship at Schneider Children’s Hospital of the Long Island Jewish Medical Center in New York. Dr. Romano is currently Associate Professor of Pediatrics at New York Medical College where she has served as Director of Pediatric Endocrine Research and has clinical, teaching, research and administrative responsibilities as a Pediatric Endocrinologist with Boston Children’s Health Physicians.
Dr. Romano has a long-standing interest in and experience with growth in patients with Noonan syndrome and advocates for growth optimization in these children. She has published adult height outcomes in the one of the largest groups of individuals with Noonan syndrome treated with growth hormone. Dr. Romano served on the Medical Advisory Board of the Noonan Syndrome Support Group, and currently serves on the Medical Advisory Board of the Noonan Syndrome Foundation.
Dr Alicia Romano has received speaker and consultation fees from Novo Nordisk, Inc, and consultation fees from Aventis.
